Mr. Sukhtian has served as a member of our Board since September 2017. Mr. Sukhtian has served as a Director of GMS Tenshi Holdings Pte. Limited since 2011, and an Executive Director of GMS Holdings, a diversified investment company, since 2008. In addition to managing operations of GMS Holdings,Mr. Sukhtian oversees a number of investments within the GMS Holdings portfolio and serves as a director of GMS Holdings’ board of directors. From 2008 to 2011, Mr. Sukhtian served as Executive Director of Munir Sukhtian International. From 2010 to 2011, he served as Managing Director of Agri Sciences Ltd., an agrochemicals manufacturing business based in Turkey. Mr. Sukhtian has served as a member of the board of directors of Expert Petroleum, an oilfield services company based in Romania, since 2008, Agri Sciences since 2010, MS Pharma, a leading MENA based branded pharmaceutical generics company, since 2011 and Stelis Biopharma Private Limited, a biotherapeutic and biosimilar developer and manufacturer based in India, since 2015. Mr. Sukhtian previously served as a member of the board ofdirectors of Alvogen, a multinational generics pharmaceutical company based in the United States, from 2008 to 2014 and Waterloo Industries, Inc., a manufacturer of tool storage based in the United States, from 2015 to 2017. Prior to joining GMS Holdings, Mr. Sukhtian worked at JP Morgan, in New York, where he worked primarily on mergers and acquisitions, debt and equity transactions serving clients in the industrials and transportation industries.
Mr. Sukhtian received an M.B.A. from Columbia Business School and a B.S. in International Economics from Georgetown University’s School of Foreign Service. Mr. Sukhtian was appointed to fill a vacancy on the Board, and was designated for such vacancy by GMS Tenshi Holdings Pte. Limited pursuant to the Investor Rights Agreement by and between the Company and GMS Tenshi Holdings Pte. Limited dated September 11, 2017.
What is Ghiath M. Sukhtian's net worth?
The estimated net worth of Ghiath M. Sukhtian is at least $37.11 million as of May 28th, 2026. Mr. Sukhtian owns 22,092,068 shares of Oncobiologics stock worth more than $37,114,674 as of July 10th. This net worth estimate does not reflect any other assets that Mr. Sukhtian may own. Learn More about Ghiath M. Sukhtian's net worth.
How do I contact Ghiath M. Sukhtian?
Has Ghiath M. Sukhtian been buying or selling shares of Oncobiologics?
Ghiath M. Sukhtian has not been actively trading shares of Oncobiologics within the last three months. Most recently, on Thursday, May 28th, Ghiath M. Sukhtian bought 8,539,709 shares of Oncobiologics stock. The stock was acquired at an average cost of $0.59 per share, with a total value of $5,038,428.31. Following the completion of the transaction, the director now directly owns 22,092,068 shares of the company's stock, valued at $13,034,320.12. Learn More on Ghiath M. Sukhtian's trading history.
Who are Oncobiologics' active insiders?
Are insiders buying or selling shares of Oncobiologics?
In the last year, Oncobiologics insiders bought shares 2 times. They purchased a total of 8,568,709 shares worth more than $5,062,498.31. The most recent insider tranaction occured on June, 2nd when Director Yezan Munther Haddadin bought 29,000 shares worth more than $24,070.00. Insiders at Oncobiologics own 1.8% of the company.
Learn More about insider trades at Oncobiologics. Information on this page was last updated on 6/2/2026.
